Literature DB >> 6988695

Ligandin: an adventure in liverland.

I M Arias, N Ohmi, M Bhargava, I Listowsky.   

Abstract

Ligandin is an abundant soluble protein which has a t 1/2 of 2--3 days, is induced by many drugs and chemicals, and is stabilized in the absence of thyroid hormone. The protein is strategically concentrated in cells associated with transport and detoxification of many endogenous ligands, such as bilirubin, and exogenous ligands, such as drugs and chemicals. The protein is a dimer in rat liver. Whether the dimer is a primary gene product or at least two genes are involved is not known. The protein has broad, low affinity catalytic activity as a GSH-S-transferase for many ligands having electrophilic groups and hydrophobic domains. It catalyzes formation of GSH conjugates, non-covalently binds some ligands prior to their biotransformation or excretion in bile, and covalently binds other ligands, such as activated carcinogens. Recent studies include the possible role of ligandin in chemical carcinogenesis, diagnosis of inflammatory and neoplastic disease of the liver and kidney, and participation in intracellular transport. Although some of the roles that have been outlined are speculative, any single function is important. The GSH-S-transferases are primitive enzymes and non-specific binding proteins but "it is precisely their simplistic design that allows such protean serviceability". Ligandin illustrates a group of hepatic disposal mechanisms which involve bulk transport of ligands. Although specific uptake and transport mechanisms have been described for several hormones which enter the hepatocyte in small quantities and regulate intermediary metabolism and, possibly, cell maturation, bulk transport of ligands into, through and out of the liver involves mechanisms which accomodate many metabolites, drugs and chemicals of diverse structure. The liver is bathed in sewage which contains what we ingest or are injected with and potentially toxic products of intestinal microorganisms. The chemical formulas of the many substances which are metabolized by the liver provide a horror show of potentially reactive and toxic metabolites, mutagens and carcinogens. Despite this alimentary "Love Canal", we and our livers do remarkably well. These hepatic disposal mechanisms, as exemplified by ligandin, evolved in ancient times. They are present, albeit sluggishly, in insects and ancient elasmobranchs. Hepatic uptake and removal mechanisms of high capacity, modest affinity and broad substrate range permit us to live in what has probably always been a threatening world.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6988695     DOI: 10.1007/BF00220301

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

1.  Purification of ligandin by affinity chromatography on sulfobromophthalein-agarose gel.

Authors:  A W Wolkoff; M M Bhargava; C Chung; Z Gatmaitan
Journal:  Proc Soc Exp Biol Med       Date:  1979-02

2.  Circular dichroism studies of Y protein (ligandin), a major organic anion binding protein in liver, kidney, and small intestine.

Authors:  K Kamisaka; I Listowsky; I M Arias
Journal:  Ann N Y Acad Sci       Date:  1973-11-26       Impact factor: 5.691

3.  Mercapturic acid formation: the several glutathione transferases of rat liver.

Authors:  M J Pabst; W H Habig; W B Jakoby
Journal:  Biochem Biophys Res Commun       Date:  1973-06-19       Impact factor: 3.575

4.  Isolation and properties of cortisol metabolite binding proteins of rat liver cytosol.

Authors:  K S Morey; G Litwack
Journal:  Biochemistry       Date:  1969-12       Impact factor: 3.162

5.  Phylogenetic study of organic anion transfer from plasma into the liver.

Authors:  R I Levine; H Reyes; A J Levi; Z Gatmaitan; I M Arias
Journal:  Nat New Biol       Date:  1971-06-30

6.  Ligandin: a hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions.

Authors:  G Litwack; B Ketterer; I M Arias
Journal:  Nature       Date:  1971-12-24       Impact factor: 49.962

7.  Ligandin. Bilirubin binding and glutathione-S-transferase activity are independent processes.

Authors:  M M Bhargava; I Listowsky; I M Arias
Journal:  J Biol Chem       Date:  1978-06-25       Impact factor: 5.157

8.  Organic anion-binding protein in rat liver: drug induction and its physiologic consequence.

Authors:  H Reyes; A J Levi; Z Gatmaitan; I M Arias
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

9.  Ligandinuria in nephrotoxic acute tubular necrosis.

Authors:  D A Feinfeld; J J Bourgoignie; G Fleischner; E J Goldstein; L Biempica; I M Arias
Journal:  Kidney Int       Date:  1977-12       Impact factor: 10.612

10.  Ligandin in steroidogenically active cells of rat gonads.

Authors:  G A Bannikov; T A Tchipyseva
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640

View more
  3 in total

1.  Characterization of hepatic glutathione S-transferases in coho salmon (Oncorhynchus kisutch).

Authors:  Mary Trute; Byron Gallis; Catalin Doneanu; Scott Shaffer; David Goodlett; Evan Gallagher
Journal:  Aquat Toxicol       Date:  2006-11-24       Impact factor: 4.964

2.  Mouse hepatic glutathione transferase isoenzymes and their differential induction by anticarcinogens. Specificities of butylated hydroxyanisole and bisethylxanthogen as inducers of glutathione transferases in male and female CD-1 mice.

Authors:  A M Benson; M J Hunkeler; J L York
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

3.  Dibromosulphophthalein: its pharmacokinetics and binding to hepatic cytosol proteins in rats with acute renal failure.

Authors:  D J Silberstein; C J Bowmer; M S Yates
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.